News

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Tracy Beth Høeg, MD, PhD, who was named a special assistant to new FDA Commissioner Marty Makary, MD, MPH, previously opposed ...
A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the ...
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
Dr. Peter Marks, a top official at the Food and Drug Administration who helped lead the U.S. effort to rapidly develop ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...